Sugammadex versus neostigmine on postoperative pulmonary complications after robot-assisted laparoscopic prostatectomy: a propensity score-matched analysis.
Jihion YuJun-Young ParkYongsoo LeeJai-Hyun HwangYoung-Kug KimPublished in: Journal of anesthesia (2021)
The incidence of PPCs after RALP was significantly lower in patients receiving sugammadex than in those receiving neostigmine. These results can provide useful information on the appropriate selection of neuromuscular blockade reversal agents in RALP.